103 related articles for article (PubMed ID: 26095011)
21. Individualized peptide-related-radionuclide-therapy concept using different radiolabelled somatostatin analogs in advanced cancer patients.
Gabriel M; Andergassen U; Putzer D; Kroiss A; Waitz D; Von Guggenberg E; Kendler D; Virgolini IJ
Q J Nucl Med Mol Imaging; 2010 Feb; 54(1):92-9. PubMed ID: 20168291
[TBL] [Abstract][Full Text] [Related]
22. Small advanced neuroendocrine carcinoma of rectum discovered in an adenomatous polyp.
Mukhopadhyay S; Marhaba A; Sidhu JS
Endoscopy; 2005 Dec; 37(12):1256-7. PubMed ID: 16329031
[No Abstract] [Full Text] [Related]
23. Solitary spinous process metastasis: a case report.
Demirçay E; Civelek E; Demiralay E
Eklem Hastalik Cerrahisi; 2013; 24(1):58-61. PubMed ID: 23441745
[TBL] [Abstract][Full Text] [Related]
24. Multiple rectal carcinoids with diffuse ganglioneuromatosis.
Haraguchi M; Kinoshita H; Koori M; Tsuneoka N; Kosaka T; Ito Y; Furui J; Kanematsu T
World J Surg Oncol; 2007 Feb; 5():19. PubMed ID: 17306015
[TBL] [Abstract][Full Text] [Related]
25. An orthotopic model of pancreatic somatostatin receptor (SSTR)-positive tumors allows bimodal imaging studies using 3T MRI and animal PET-based molecular imaging of SSTR expression.
Stelter L; Amthauer H; Rexin A; Pinkernelle J; Schulz P; Michel R; Denecke T; Stiepani H; Hamm B; Wiedenmann B; Scholz A
Neuroendocrinology; 2008; 87(4):233-42. PubMed ID: 18025811
[TBL] [Abstract][Full Text] [Related]
26. Long-Term Follow-up in Medullary Thyroid Carcinoma.
Raue F; Frank-Raue K
Recent Results Cancer Res; 2015; 204():207-25. PubMed ID: 26494391
[TBL] [Abstract][Full Text] [Related]
27. Metastatic neuroendocrine carcinoma presenting as a "Superscan" on 68Ga-DOTANOC somatostatin receptor PET/CT.
Naswa N; Karunanithi S; Soundararajan R; Das KJ; Agarwal KK; Malhotra A; Bal C; Kumar R
Clin Nucl Med; 2012 Sep; 37(9):892-4. PubMed ID: 22889781
[TBL] [Abstract][Full Text] [Related]
28. [Analysis of clinicopathological features of intestinal neuroendocrine neoplasms].
Gao W; Liu SM; Lu HZ; Liang J; Yuan YL; Liu XY
Zhonghua Zhong Liu Za Zhi; 2012 Jun; 34(6):450-6. PubMed ID: 22967448
[TBL] [Abstract][Full Text] [Related]
29. Comparison of ⁶⁸Ga-DOTATATE PET-CT, ¹⁸F-FDG PET-CT and 99mTc-(V)DMSA scintigraphy in the detection of recurrent or metastatic medullary thyroid carcinoma.
Ozkan ZG; Kuyumcu S; Uzum AK; Gecer MF; Ozel S; Aral F; Adalet I
Nucl Med Commun; 2015 Mar; 36(3):242-50. PubMed ID: 25369749
[TBL] [Abstract][Full Text] [Related]
30. The role of 68Ga-DOTATATE PET in patients with neuroendocrine tumors and negative or equivocal findings on 111In-DTPA-octreotide scintigraphy.
Srirajaskanthan R; Kayani I; Quigley AM; Soh J; Caplin ME; Bomanji J
J Nucl Med; 2010 Jun; 51(6):875-82. PubMed ID: 20484441
[TBL] [Abstract][Full Text] [Related]
31. Dose response of pancreatic neuroendocrine tumors treated with peptide receptor radionuclide therapy using 177Lu-DOTATATE.
Ilan E; Sandström M; Wassberg C; Sundin A; Garske-Román U; Eriksson B; Granberg D; Lubberink M
J Nucl Med; 2015 Feb; 56(2):177-82. PubMed ID: 25593115
[TBL] [Abstract][Full Text] [Related]
32. The Impact of 68Ga-DOTATATE PET/CT Imaging on Management of Patients with Neuroendocrine Tumors: Experience from a National Referral Center in the United Kingdom.
Skoura E; Michopoulou S; Mohmaduvesh M; Panagiotidis E; Al Harbi M; Toumpanakis C; Almukhailed O; Kayani I; Syed R; Navalkissoor S; Ell PJ; Caplin ME; Bomanji J
J Nucl Med; 2016 Jan; 57(1):34-40. PubMed ID: 26471695
[TBL] [Abstract][Full Text] [Related]
33. Ghrelin-producing well-differentiated neuroendocrine tumor (carcinoid) of tailgut cyst. Morphological, immunohistochemical, ultrastructural, and RT-PCR study of a case and review of the literature.
La Rosa S; Boni L; Finzi G; Vigetti D; Papanikolaou N; Tenconi SM; Dionigi G; Clerici M; Garancini S; Capella C
Endocr Pathol; 2010 Sep; 21(3):190-8. PubMed ID: 20532674
[TBL] [Abstract][Full Text] [Related]
34. Comparison of Ga-68 DOTA-TATE and Ga-68 DOTA-LAN PET/CT imaging in the same patient group with neuroendocrine tumours: preliminary results.
Demirci E; Ocak M; Kabasakal L; Araman A; Ozsoy Y; Kanmaz B
Nucl Med Commun; 2013 Aug; 34(8):727-32. PubMed ID: 23728519
[TBL] [Abstract][Full Text] [Related]
35. Poorly differentiated synovial sarcoma of the lumbar spine in a fourteen-year-old girl. A case report.
Barus CE; Monsey RD; Kalof AN
J Bone Joint Surg Am; 2009 Jun; 91(6):1471-6. PubMed ID: 19487526
[No Abstract] [Full Text] [Related]
36. Use of radioactive substances in diagnosis and treatment of neuroendocrine tumors.
Kjaer A; Knigge U
Scand J Gastroenterol; 2015 Jun; 50(6):740-7. PubMed ID: 25959100
[TBL] [Abstract][Full Text] [Related]
37. Metastatic breast neuroendocrine tumor from the rectum.
Al-Maghrabi JA; Zekri J
Saudi Med J; 2012 Jun; 33(6):676-9. PubMed ID: 22729125
[TBL] [Abstract][Full Text] [Related]
38. Impact of (68)Ga-DOTATATE PET/CT on the surgical management of primary neuroendocrine tumors of the pancreas or ileum.
Ilhan H; Fendler WP; Cyran CC; Spitzweg C; Auernhammer CJ; Gildehaus FJ; Bartenstein P; Angele MK; Haug AR
Ann Surg Oncol; 2015 Jan; 22(1):164-71. PubMed ID: 25190113
[TBL] [Abstract][Full Text] [Related]
39. Major hyperghrelinemia in advanced well-differentiated neuroendocrine carcinomas: report of three cases.
Walter T; Chardon L; Hervieu V; Cohen R; Chayvialle JA; Scoazec JY; Lombard-Bohas C
Eur J Endocrinol; 2009 Oct; 161(4):639-45. PubMed ID: 19605542
[TBL] [Abstract][Full Text] [Related]
40. Peptide receptor radionuclide therapy of Merkel cell carcinoma using (177)lutetium-labeled somatostatin analogs in combination with radiosensitizing chemotherapy: a potential novel treatment based on molecular pathology.
Salavati A; Prasad V; Schneider CP; Herbst R; Baum RP
Ann Nucl Med; 2012 May; 26(4):365-9. PubMed ID: 22361935
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]